Loading…
Venus Remedies (VENUSREM)₹1,448−4.14%Pharmaceuticals
At the end of the Sep 2026 quarter, Venus Remedies' shareholders were: promoters 41.74%, FIIs 3.13%, DIIs 0.74%, public 54.39%. Promoter holding is unchanged on the quarter. FII holding is up 1.28 percentage points from 1.85% a year earlier. 0.00% of promoter shares were pledged. It had 22,958 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 41.74% | 41.74% | 41.74% | 41.74% | 41.74% | 41.74% | 41.74% | 41.74% | 41.74% | 41.74% | 41.74% | 41.74% |
| FIIs | 1.58% | 1.47% | 1.05% | 1.17% | 1.10% | 1.33% | 2.24% | 1.85% | 2.24% | 2.79% | 2.91% | 3.13% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.11% | 0.75% | 1.04% | 1.21% | 0.89% | 0.74% |
| Public | 56.68% | 56.79% | 57.21% | 57.09% | 57.16% | 56.93% | 55.91% | 55.66% | 54.98% | 54.26% | 54.46% | 54.39% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 19,552 | 19,904 | 19,606 | 19,549 | 19,763 | 19,973 | 19,299 | 17,717 | 18,598 | 18,395 | 21,896 | 22,958 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Sunev Pharma Solutions Pvt Ltd | Promoter | 17.20% | 0.00 |
| Pawan Chaudhary | Promoter | 12.78% | 0.00 |
| Manu Chaudhary | Promoter | 11.79% | 0.00 |
| Tikri Partners Llp | Public | 1.95% | 0.00 |
| Rajni Tarun Jain | Public | 1.41% | 0.00 |
| Acadian Emerging Markets Micro-Cap Equity Master Fund | FII | 1.11% | 0.00 |
| Nisarg Ajaykumar Vakharia | Public | 1.04% | 0.00 |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | Public | 0.99% | New |
| Investor Education & Protection Fund (IEPF( | Public | Exited | — |
Promoters held 41.74% of Venus Remedies at the end of the Sep 2026 quarter, the same as a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 3.13% (up 0.22 percentage points from 2.91% a quarter earlier) and domestic institutions (DIIs) held 0.74% (down 0.15 percentage points from 0.89% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Venus Remedies had 22,958 shareholders at the end of the Sep 2026 quarter, against 17,717 a year earlier.
Tikri Partners Llp (Public) held 1.95% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.